Inhibition of the pituitary-adrenal system in humans evaluated by the metyrapone test and gas-liquid chromatography estimation of urinary 17-OHCS during and after oral administration of prednisolone-21-stearoylglycolate and othe glucocorticoids.
D015065:17-Hydroxycorticosteroids / Q000652:urine*; D000328:Adult; D001623:Betamethasone / Q000494:pharmacology; D002849:Chromatography, Gas; D003864:Depression, Chemical; D003907:Dexamethasone / Q000494:pharmacology; D005938:Glucocorticoids / Q000494:pharmacology*; D006801:Humans; D008297:Male; D008722:Methods; D008797:Metyrapone; D010912:Pituitary-Adrenal Function Tests; D010913:Pituitary-Adrenal System / Q000187:drug effects*; D011239:Prednisolone / Q000494:pharmacology; D014221:Triamcinolone / Q000494:pharmacology
D015065:17-Hydroxycorticosteroids; D005938:Glucocorticoids; D014221:Triamcinolone; D003907:Dexamethasone; D001623:Betamethasone; D011239:Prednisolone; D008797:Metyrapone